Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing high-quality pharmaceutical ingredients to support advanced medical treatments. One such crucial compound is Lapatinib Ditosylate Monohydrate, a vital component in the fight against certain types of breast cancer. This article aims to shed light on its function, application, and what patients and healthcare providers should know.
Lapatinib Ditosylate Monohydrate is a targeted therapy drug, specifically a receptor tyrosine kinase (RTK) inhibitor. Its primary role is in treating specific subtypes of breast cancer, particularly those that are HER2-positive. For patients with HER2-positive advanced breast cancer that has shown resistance or progression after standard chemotherapeutic agents such as anthracyclines, taxanes, or trastuzumab, Lapatinib Ditosylate Monohydrate offers a new avenue for treatment. It is also indicated for treatment-naïve patients with ER+/EGFR+/HER2+ breast cancer.
The mechanism of action for Lapatinib Ditosylate Monohydrate involves inhibiting the activity of ErbB-1 (also known as EGFR) and ErbB-2 (also known as HER2) receptors. These receptors play a critical role in the growth and proliferation of cancer cells. By binding to the ATP-binding site of these receptors, Lapatinib Ditosylate Monohydrate prevents phosphorylation and subsequent activation of downstream signaling pathways that drive cancer cell growth. This targeted approach is a cornerstone of modern cancer therapy, aiming to be more effective and less toxic than traditional chemotherapy.
For those seeking to buy Lapatinib Ditosylate Monohydrate, it is essential to source from reputable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. who ensure product purity and consistent quality. The price of Lapatinib Ditosylate Monohydrate can vary, but focusing on value and efficacy is paramount for treatment success. Understanding the Lapatinib Ditosylate Monohydrate manufacturer's commitment to quality control is key when making a purchase decision.
Commonly reported side effects associated with Lapatinib Ditosylate Monohydrate therapy include skin rash and diarrhea. Skin rash is a known side effect for many TK inhibitors, while Lapatinib-induced diarrhea is typically mild to moderate. In rare cases, a decrease in left ventricular ejection fraction has been reported, which is usually reversible upon discontinuation of the medication. Patients should discuss any concerns with their healthcare provider.
NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting advancements in cancer treatment by supplying high-quality pharmaceutical intermediates and APIs. For inquiries about Lapatinib Ditosylate Monohydrate suppliers or to understand the Lapatinib Ditosylate Monohydrate purchase process, please reach out to us. We strive to be your trusted partner in sourcing critical pharmaceutical ingredients.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
